Massachusetts Financial Services CO Medpace Holdings, Inc. Transaction History

Massachusetts Financial Services CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$174.31 - $239.52 $3.42 Million - $4.7 Million	-19,623 Reduced 34.96%	36,514 $6.87 Million
Q4 2022 Feb 13, 2023	BUY	$153.06 - $226.57 $1.56 Million - $2.32 Million	10,222 Added 22.26%	56,137 $11.9 Million
Q3 2022 Nov 09, 2022	BUY	$145.13 - $182.49 $5.32 Million - $6.7 Million	36,689 Added 397.67%	45,915 $7.22 Million
Q2 2022 Aug 09, 2022	BUY	$130.2 - $168.03 $1.2 Million - $1.55 Million	9,226 New	9,226 $1.38 Million
Q3 2020 Nov 12, 2020	SELL	$92.95 - $130.61 $992,706 - $1.39 Million	-10,680 Closed	0 $0

Q2 2020 Aug 11, 2020	SELL	$68.08 - $95.68 $450,553 - $633,210	-6,618 Reduced 38.26%	10,680 $993,000
Q1 2020 May 14, 2020	BUY	$61.71 - $101.95 $168,961 - $279,139	2,738 Added 18.8%	17,298 $1.27 Million
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $1.02 Million - $1.23 Million	14,560 New	14,560 $1.22 Million

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.